Mind Medicine (FRA:MMQ) Cash And Cash Equivalents : €232.15 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Mind Medicine Cash And Cash Equivalents?

Mind Medicine's quarterly cash and cash equivalents declined from Sep. 2023 (€110.28 Mil) to Dec. 2023 (€91.43 Mil) but then increased from Dec. 2023 (€91.43 Mil) to Mar. 2024 (€232.15 Mil).

Mind Medicine's annual cash and cash equivalents increased from Dec. 2021 (€118.18 Mil) to Dec. 2022 (€134.18 Mil) but then declined from Dec. 2022 (€134.18 Mil) to Dec. 2023 (€91.43 Mil).

Mind Medicine Cash And Cash Equivalents Historical Data

The historical data trend for Mind Medicine's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Cash And Cash Equivalents Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

65.84

118.18

134.18

91.43

Mind Medicine Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial													120.87	107.89	110.28	91.43	232.15

Mind Medicine Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Mind Medicine (FRA:MMQ) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Mind Medicine Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Mind Medicine's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine (FRA:MMQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (FRA:MMQ) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMQ:Germany

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

Mind Medicine (FRA:MMQ) Headlines

No Headlines